Track topics on Twitter Track topics that are important to you
The Company is based around original concepts and discoveries made by Prof. Tom Cotter (CSO). Tom is a leading international expert in this field and is Professor of Biochemistry at University College Cork.
The goal of applied research in apoptosis is to develop new drugs that effectively modulate apoptosis in disease states in a safe manner. EiRx Therapeutics believes that there will be significant advantages to identifying novel early points of intervention in the cell death process.
In particular such novel targets will provide more effective control than drugs targeted at later stages in the death process. In addition the company is focused on identifying targets with restricted cellular expression that will provide a greater degree of specificity in drugs directed against these targets.
While apoptosis is central to much of cancer research the application of apoptosis research to other therapeutic categories presents exciting new opportunities. EiRx Therapeutics isfocused in two core areas, Cancer and Inflammation
2800 Airport Business Park,Kinsale Road,
Phone: +353 (0)21 4320847
Fax: +353 (0)21 4320848
Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...
Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.
Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.
ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...
About Capricor Therapeutics Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biolog...
http://dailystocktracker.com/register/ Cytori Therapeutics San Diego, Californiaheadquartered Cytori Therapeutics Inc.'s shares dropped 2.15%, closing Monday's trading session at $0.39. The stock ...
Summit Therapeutics plc ('Summit', or the 'Company')SUMMIT THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESOxford, UK, 22 November 2017- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUM...
CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...
ALDEX GS™ Tablets
ALDEX GS DMTablets
The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...
Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System
The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...
The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...
This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...
EiRx Therapeutics is a specialist provider of pre-clinical therapeutics to the pharmaceutical industry. Our unique scientific expertise and knowledge in the field of Apoptosis provide a sound base to ...
The Company is based around original concepts and discoveries made by Prof. Tom Cotter (CSO). Tom is a leading international expert in this field and is Professor of Biochemistry at University College...
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
Millendo Therapeutics is focused on developing a portfolio of disease-modifying treatments for endocrine diseases caused by hormone dysregulation. Our product candidates seek to i...
Circadian Technologies Limited is an emerging leader in the field of angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs),...
We have published hundreds of EiRx Therapeutics Limited news stories on BioPortfolio along with dozens of EiRx Therapeutics Limited Clinical Trials and PubMed Articles about EiRx Therapeutics Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EiRx Therapeutics Limited Companies in our database. You can also find out about relevant EiRx Therapeutics Limited Drugs and Medications on this site too.